Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Macrolides. New therapeutic prospects]

A Bryskier1, M T Labro

  • 1Laboratoire de Microbiologie, Centre Hospitalier Victor Dupouy, Argenteuil.

Presse Medicale (Paris, France : 1983)
|December 3, 1994
PubMed
Summary

New macrolide antibiotics offer improved stability and absorption compared to erythromycin A. These semisynthetic derivatives maintain a broad antibacterial spectrum and are effective against various infections, including respiratory and sexually transmitted diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunological effects of macrolides.

Current opinion in infectious diseases·2006
Same author

Interaction of rifalazil with oxidant-generating systems of human polymorphonuclear neutrophils.

Antimicrobial agents and chemotherapy·2005
Same author

Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR).

Journal of chemotherapy (Florence, Italy)·2005
Same author

Antibacterial drug discovery and development--third international summit. 8-9 March 1999, Princeton, NJ, USA.

IDrugs : the investigational drugs journal·2005
Same author

Novelties in the field of fluoroquinolones.

Expert opinion on investigational drugs·2005
Same author

New research in macrolides and ketolides since 1997.

Expert opinion on investigational drugs·2005

Area of Science:

  • Pharmaceutical Chemistry
  • Microbiology
  • Pharmacology

Context:

  • Erythromycin A's chemical instability in acidic environments and variable gastrointestinal absorption limited its therapeutic use.
  • Development of semisynthetic macrolide derivatives aims to enhance stability and pharmacokinetic profiles.
  • Macrolides represent a class of well-tolerated antibacterial agents with a broad spectrum of activity.

Purpose:

  • To develop semisynthetic macrolide derivatives with improved chemical stability and gastrointestinal absorption.
  • To evaluate the antibacterial spectrum and therapeutic potential of new macrolides.
  • To explore novel applications of macrolides, including antiparasitic and combination therapies.

Summary:

  • New macrolides (e.g., roxithromycin, azithromycin, clarithromycin) exhibit enhanced stability and absorption over erythromycin A.
  • These agents retain the broad-spectrum activity of erythromycin A, effective against Gram-positive and Gram-negative bacteria, intracellular pathogens, and mycoplasmas.
  • Indications include respiratory tract infections, non-gonococcal urethritis, pelvic inflammatory disease, and potential uses in H. pylori, Lyme disease, and Mycobacterium avium-intracellulare infections.

Impact:

  • Semisynthetic macrolides offer improved therapeutic options for bacterial infections due to enhanced pharmacokinetic properties.
  • Expanded applications are being investigated, including antiparasitic effects and overcoming cross-resistance.
  • Continued research focuses on broadening the antibacterial spectrum and addressing resistance mechanisms in macrolide antibiotics.

Related Experiment Videos